Hs578T breast cancer cells, which also express HRas, were similarly resistant to the inhibitory effects of IGFBP-3 but were resensitized to it in the presence of PD98059, an inhibitor of p44/42MAPK [43]. Here, IGFBP3 is linked to breast carcinoma.